Short Term and Long Term Outcome for Elderly Patients Treated With Total Hip Replacement (THR)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Know the risks and potential benefits of clinical studies and talk to your health care provider before participating.
Read our disclaimer for details.
The is a retrospective analysis to study the characteristics of elderly patients treated with total hip replacements during past 5 years．
Condition or disease
Total Hip Replacement
Procedure: total hip replacement
Patients underwent total hip replacement due to removal of the hip caused by retrogressive lesions, is conducive to the improvement of hip function .But at the same time,the complications from patients accepted total hip replacement surgery will directly or indirectly affect the prognosis of the patients, resulting in patients with delayed recovery and increase the hospitalization time and cost. Serious complications can lead to patients deaths during perioperative period. This study was designed to provide a retrospective analysis of postoperative recovery, quality of life, and complications in patients undergoing hip replacement over the past five years, providing data for clinical studies.
Quality of life during 5 years after surgery [ Time Frame: 5 years ]
evaluate the quality of life after surgery by WHO QOL-BREF scale with interview ，WHO QOL-BREF scale includes five aspects: physical, psychological, social, environmental, integrated, divided into five levels
Secondary Outcome Measures :
The incidence of postoperative complications [ Time Frame: from 7 days to 1 year ]
Participants will be followed for the incidence of postoperative complications
Mortality during 5 years after surgery [ Time Frame: during 5 years ]
Participants will be followed for Survival rate during 5 years after surgery
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
60 Years to 89 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
From January 2012 to July 30，2017，approximately 1500 cases of primary hip replacement in this study，including male ，female and bilateral replacements．
ASA Ⅱ-Ⅲ,elective operation patients，
NO other severe complication history
Having severe comorbidity
not for the first time of joint replacement
Suffered from neurologic disorder or impaired mental state